Evidence map›Paper›PMID 19239276›Full record

ArticleBiomacromolecules2009

Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles.

Yuhua Hu, Prabhani U Atukorale, James J Lu, James J Moon, Soong Ho Um, Eun Chol Cho, Yana Wang, Jianzhu Chen, Darrell J Irvine

Open access · greenAbstract read
In one paragraph

Article in Biomacromolecules, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Smart pH-responsive nanomedicines for disease therapy.Journal of pharmaceutical investigation · 2022
    Review
  4. Review
  5. Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Stimulus-responsive hydrogels: Theory, modern advances, and applications.Materials science & engineering. R, Reports : a review journal · 2015
    Article
  11. Stimuli-responsive nanomaterials for therapeutic protein delivery.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Review
  12. Materials based tumor immunotherapy vaccines.Current opinion in immunology · 2013
    Review
  13. Review
  14. Biomaterials-based modulation of the immune system.BioMed research international · 2013
    Review
  15. Article
  16. Engineering nano- and microparticles to tune immunity.Advanced materials (Deerfield Beach, Fla.) · 2012
    Review
  17. Article
  18. Article
  19. Article
  20. Controlled protein delivery based on enzyme-responsive nanocapsules.Advanced materials (Deerfield Beach, Fla.) · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuhua HuDepartment of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
Prabhani U Atukorale
James J Lu
James J Moon
Soong Ho Um
Eun Chol Cho
Yana Wang
Jianzhu Chen
Darrell J Irvine
Howard Hughes Medical Institute · USMassachusetts Institute of Technology · US

Funding

Tumor Cell Networks CenterU54CA112967 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LAUFFENBURGER, DOUGLAS A · 2004 to 2015
$26.2M
TREATMENT OF CANCER WITH siRNA DELVIERED BY NANOPARTICLESU54CA119349 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELCHER, ANGELA M. · 2005 to 2009
$20.5M
Howard Hughes Medical InstituteNCI NIH HHS CA112967NCI NIH HHS CA119349NCI NIH HHS U54 CA112967NCI NIH HHS U54 CA119349
6 · The paper itself

Abstract

We recently described a strategy for intracellular delivery of macromolecules, utilizing pH-responsive "core-shell" structured gel particles. These cross-linked hydrogel particles disrupt endosomes with low toxicity by virtue of physical sequestration of an endosome-disrupting "proton sponge" core inside a nontoxic hydrophilic shell. Here we tested the efficacy of this system for cytosolic delivery of a broad range of macromolecular cargos, and demonstrate the delivery of proteins, whole viral particles, or siRNA oligonucleotides into the cytosol of dendritic cells and epithelial cells via core-shell particles. We assessed the functional impact of particle delivery for vaccine applications and found that cytosolic delivery of protein antigens in dendritic cells via the core-shell particles promotes priming of CD8(+) T-cells at 100-fold lower doses than soluble protein. Functional gene knockdown following delivery of siRNA using the particles was demonstrated in epithelial cells. Based on these findings, these materials may be of interest for a broad range of biomedical applications.

Indexed as

AnimalsBone MarrowCD8-Positive T-LymphocytesCytosolDendritic CellsDrug Delivery SystemsEndosomesFemaleGelsGene Knockdown TechniquesHydrogen-Ion ConcentrationInfluenza A virusMiceMice, Inbred C57BLMice, TransgenicMonocytesGelsOvalbuminReceptors, Antigen, T-CellRNA, Small Interfering

Identifiers

PMID19239276
PMCPMC2769516
OpenAlexW2016159994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.